These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6166710)

  • 21. Inhibition of pathogenic effect of effector T cells by specific suppressor T cells during influenza virus infection in mice.
    Liew FY; Russell SM
    Nature; 1983 Aug 11-17; 304(5926):541-3. PubMed ID: 6224092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Production of DTH in the mouse to influenza virus: comparison with conditions for stimulation of cytotoxic T cells.
    Leung KN; Ada GL
    Scand J Immunol; 1980; 12(2):129-39. PubMed ID: 6255555
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of 2'-deoxyguanosine upon the development of DTH effector T cells and suppressor T cells in vivo.
    Bril H; van den Akker TW; Molendijk-Lok BD; Bianchi AT; Benner R
    J Immunol; 1984 Feb; 132(2):599-604. PubMed ID: 6228591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A requirement for helper T cells in the induction of delayed-type hypersensitivity.
    Wright K; Ramshaw IA
    J Immunol; 1983 Apr; 130(4):1596-9. PubMed ID: 6187816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective suppression of the cytotoxic T cell response to influenza virus in mice.
    Leung K; Ashman RB; Ertl HC; Ada GL
    Eur J Immunol; 1980 Nov; 10(11):803-10. PubMed ID: 6970126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Delayed-type hypersensitivity initiation by early-acting cells that are antigen mismatched or MHC incompatible with late-acting, delayed-type hypersensitivity effector T cells.
    Ptak W; Herzog WR; Askenase PW
    J Immunol; 1991 Jan; 146(2):469-75. PubMed ID: 1987274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The mechanism of tolerance induction of tumor-specific delayed-type hypersensitivity responses by intravenous inoculation of tumor cells.
    Sato S; Fukuzawa M; Nakajima H; Ogata M; Kosugi A; Fujiwara H; Hamaoka T
    Jpn J Cancer Res; 1985 Nov; 76(11):1099-106. PubMed ID: 2935516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T cells expressing delayed-type hypersensitivity can be derived from a humorally immune lymphocyte population.
    LeClercq SA; Bretscher PA
    Eur J Immunol; 1987 Jul; 17(7):949-54. PubMed ID: 3497043
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antigen presentation by Langerhans cells in vivo: donor-derived Ia+ Langerhans cells are required for induction of delayed-type hypersensitivity but not for cytotoxic T lymphocyte responses to alloantigens.
    Peeler JS; Niederkorn JY
    J Immunol; 1986 Jun; 136(12):4362-71. PubMed ID: 3519767
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The generation of effector T cells in influenza A-infected, cyclosporine A-treated mice.
    Schiltknecht E; Ada GL
    Cell Immunol; 1985 Oct; 95(2):340-8. PubMed ID: 3876162
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunoregulatory pathways in adult responder mice. III. Establishment of a GAT-specific suppressor T cell clone from GAT-tolerant responders which afferently regulates DTH responses.
    Jenkins MK; Miller SD
    J Mol Cell Immunol; 1985; 2(1):1-13. PubMed ID: 2978221
    [TBL] [Abstract][Full Text] [Related]  

  • 32. T cell lines active in the delayed-type hypersensitivity reaction (DTH).
    Weiss S; Dennert G
    J Immunol; 1981 May; 126(5):2031-5. PubMed ID: 6971319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T-enriched spleen cells in delayed-type hypersensitivity to influenza virus in mice.
    Ochałek T; Porwit-Bóbr Z; Radzioch D
    Arch Immunol Ther Exp (Warsz); 1985; 33(4):549-56. PubMed ID: 3878696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Virus-replicating T cells in the immune response of mice. I. Virus plaque assay of the lymphocytes reactive to sheep erythrocytes.
    Minato N; Katsura Y
    J Exp Med; 1977 Feb; 145(2):390-404. PubMed ID: 64584
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of delayed-type hypersensitivity. VII. The role of I-J subregion gene products in the inhibition of delayed-type hypersensitivity to major histocompatibility antigens by specific suppressor T cells.
    Liew FY
    Eur J Immunol; 1981 Nov; 11(11):883-8. PubMed ID: 6173227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cells mediating delayed-type hypersensitivity in the lungs of mice infected with an influenza A virus.
    Leung KN; Ada GL
    Scand J Immunol; 1980; 12(5):393-400. PubMed ID: 7466327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The DTH-initiating Thy-1+ cell is double-negative (CD4-, CD8-) and CD3-, and expresses IL-3 receptors, but no IL-2 receptors.
    Herzog WR; Ferreri NR; Ptak W; Askenase PW
    J Immunol; 1989 Nov; 143(10):3125-33. PubMed ID: 2478617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Delayed-type hypersensitivity and allograft rejection in the mouse: correlation of effector cell phenotype.
    Loveland BE; McKenzie IF
    Immunology; 1982 Jun; 46(2):313-20. PubMed ID: 7044959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies on the mechanism of the enhancement of delayed-type hypersensitivity by pertussigen.
    Sewell WA; Munoz JJ; Scollay R; Vadas MA
    J Immunol; 1984 Oct; 133(4):1716-22. PubMed ID: 6206132
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of accessory cell processing and presentation of shed H-2 alloantigens in allospecific cytotoxic T lymphocyte responses.
    Golding H; Singer A
    J Immunol; 1984 Aug; 133(2):597-605. PubMed ID: 6203969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.